結晶型硫酸鹽葡萄糖胺 – 骨科醫生推薦No.1 藥物*


  • 參考資料PM-COR-22-112808

    1. Viartril®-S (crystalline glucosamine sulphate) 250 mg & 500 mg Capsules Package Insert. Viatris Healthcare Hong Kong: Version L1086D.
    2. Viartril®-S (crystalline glucosamine sulphate) 1500 mg Sachets Package Insert. Viatris Healthcare Hong Kong: Version L1019F.
    3. Eriksen P, Bartels EM, Altman RD, Bliddal H, Juhl C, Christensen R. Risk of bias and brand explain the observed inconsistency in trials on glucosamine for symptomatic relief of osteoarthritis: a meta-analysis of placebo-controlled trials. Arthritis Care Res (Hoboken). 2014;66(12):1844-1855.
    4. Kucharz EJ, Kovalenko V, Szanto S, Bruyere O, Cooper C, Reginster JY. A review of glucosamine for knee osteoarthritis: why patented crystalline glucosamine sulfate should be differentiated from other glucosamines to maximize clinical outcomes. Curr Med Res Opin. 2016;32(6):997-1004.
    5. Sun Y, Wang C, Gong C. Repairing effects of glucosamine sulfate in combination with etoricoxib on articular cartilages of patients with knee osteoarthritis. J Orthop Surg Res. 2020;15(1):150.
    6. Bruyere O, Altman RD, Reginster JY. Efficacy and safety of glucosamine sulfate in the management of osteoarthritis: Evidence from real-life setting trials and surveys. Semin Arthritis Rheum. 2016;45(4 Suppl):S12-S17.
    7. Bruyere O, Pavelka K, Rovati LC, et al. Total joint replacement after glucosamine sulphate treatment in knee osteoarthritis: results of a mean 8-year observation of patients from two previous 3-year, randomised, placebo-controlled trials. Osteoarthritis Cartilage. 2008;16(2):254-260.
    8. Pharmaceutically active glucosamine salts useful in the treatment of osteoarthritis and rheumatoid arthritis (US3683076A). Google Patents. 1972. Available at: Accessed on February 13, 2023.
    9. Professor Luigi Rovati. Fondazione Luigi Rovati. Available at: Accessed on February 13, 2023.
    10. Viartril®-S capsules 314 mg registration. Hong Kong Department of Health. 2021. Available at: Accessed on February 13, 2023.
    11. Bruyere O, Cooper C, Pelletier JP, et al. A consensus statement on the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) algorithm for the management of knee osteoarthritis-From evidence-based medicine to the real-life setting. Semin Arthritis Rheum. 2016;45(4 Suppl):S3-S11.